insights_auto
Why is CSBR down 3.14%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
$4.63
arrow_downward
-3.14%(-0.15) 1D
Nov 12, 10:29:50 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.64
High
$4.70
Low
$4.60
Mkt. cap
64.44M
Avg. vol.
8.11K
Volume
925.00
52-wk high
$8.31
52-wk low
$4.59
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.64
High
$4.70
Low
$4.60
Mkt. cap
64.44M
Avg. vol.
8.11K
Volume
925.00
52-wk high
$8.31
52-wk low
$4.59
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
Quartz
·
1 hour ago
Nvidia stock sinks after Jensen Huang resigns; S&P 500, Nasdaq fall
24/7 Wall St.
·
55 minutes ago
The S&P 500 Lost 5.9% in a Month, Then Won Back More Than Half in 4 Trading Days. How Much Does a 72-Year-Old Widow Need in Dividend Stocks to Collect $5,000 a Month?
24/7 Wall St.
·
15 minutes ago
NVIDIA’s Leadership Crisis Is Dragging the S&P 500 Lower. Here’s What Else Is Moving
ChartMill
·
2 hours ago
S&P 500 Premarket Losers Led by NVIDIA, Sandisk, and Super Micro on Nov. 12
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com